Impact of the HLA-DRB1 shared epitope on responses to treatment with tofacitinib or abatacept in patients with rheumatoid arthritis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Impact of the HLA-DRB1 shared epitope on responses to treatment with tofacitinib or abatacept in patients with rheumatoid arthritis ; volume:23 ; number:1 ; day:31 ; month:8 ; year:2021 ; pages:1-12 ; date:12.2021
Arthritis Research & Therapy ; 23, Heft 1 (31.8.2021), 1-12, 12.2021
- Creator
-
Hirose, Wataru
Harigai, Masayoshi
Amano, Koichi
Hidaka, Toshihiko
Itoh, Kenji
Aoki, Kazutoshi
Nakashima, Masahiro
Nagasawa, Hayato
Komano, Yukiko
Nanki, Toshihiro
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-021-02612-w
- URN
-
urn:nbn:de:101:1-2021111405583576634492
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hirose, Wataru
- Harigai, Masayoshi
- Amano, Koichi
- Hidaka, Toshihiko
- Itoh, Kenji
- Aoki, Kazutoshi
- Nakashima, Masahiro
- Nagasawa, Hayato
- Komano, Yukiko
- Nanki, Toshihiro
- SpringerLink (Online service)
Other Objects (12)
Association of HLA-DRB1 locus with treatment response to abatacept or TNF inhibitors in patients with seropositive rheumatoid arthritis
Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+
B lymphocytopenia in rheumatoid arthritis is associated with the DRB1 shared epitope and increased acute phase response
Validation of the reshaped shared epitope HLA-DRB1 classification in rheumatoid arthritis
The lupus susceptibility allele DRB1*03:01 encodes a disease-driving epitope
Carriers of HLA-DRB1*04:05 have a better clinical response to abatacept in rheumatoid arthritis
Experience with abatacept in refractory lupus nephritis
Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients
Association of HLA-DRB1*11 and HLA-DRB1*12 gene polymorphism with COVID-19 in Burkina Faso
Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity
T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles
Evidence for an association of HLA-DRB1*15 and DRB1*09 with leprosy and the impact of DRB1*09 on disease onset in a Chinese Han population
Association of HLA-DRB1 locus with treatment response to abatacept or TNF inhibitors in patients with seropositive rheumatoid arthritis
Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+
B lymphocytopenia in rheumatoid arthritis is associated with the DRB1 shared epitope and increased acute phase response
Validation of the reshaped shared epitope HLA-DRB1 classification in rheumatoid arthritis
The lupus susceptibility allele DRB1*03:01 encodes a disease-driving epitope
Carriers of HLA-DRB1*04:05 have a better clinical response to abatacept in rheumatoid arthritis
Experience with abatacept in refractory lupus nephritis
Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients
Association of HLA-DRB1*11 and HLA-DRB1*12 gene polymorphism with COVID-19 in Burkina Faso
Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity
T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles
Evidence for an association of HLA-DRB1*15 and DRB1*09 with leprosy and the impact of DRB1*09 on disease onset in a Chinese Han population
Association of HLA-DRB1 locus with treatment response to abatacept or TNF inhibitors in patients with seropositive rheumatoid arthritis
Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+
B lymphocytopenia in rheumatoid arthritis is associated with the DRB1 shared epitope and increased acute phase response
Validation of the reshaped shared epitope HLA-DRB1 classification in rheumatoid arthritis
The lupus susceptibility allele DRB1*03:01 encodes a disease-driving epitope
Carriers of HLA-DRB1*04:05 have a better clinical response to abatacept in rheumatoid arthritis
Experience with abatacept in refractory lupus nephritis
Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients
Association of HLA-DRB1*11 and HLA-DRB1*12 gene polymorphism with COVID-19 in Burkina Faso
Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity
T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles